-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IJC+1ztBN80YQ4n5/7LJzT2PkKwE5RR7LYNdl1GupT9j1A5j6G1sYR/17YA+IwbY i9qf9QGWD7L5QyOnsJuOFg== 0000950136-99-000004.txt : 19990107 0000950136-99-000004.hdr.sgml : 19990107 ACCESSION NUMBER: 0000950136-99-000004 CONFORMED SUBMISSION TYPE: SC 14D1/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19990106 GROUP MEMBERS: MAXXIM MEDICAL INC GROUP MEMBERS: MAXXIM MEDICAL, INC. GROUP MEMBERS: MMI ACQUISITION CORP. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CIRCON CORP CENTRAL INDEX KEY: 0000719727 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 953079904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 14D1/A SEC ACT: SEC FILE NUMBER: 005-36096 FILM NUMBER: 99501674 BUSINESS ADDRESS: STREET 1: 6500 HOLLISTER AVE CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: 8059670404 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MAXXIM MEDICAL INC CENTRAL INDEX KEY: 0000858660 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 760291634 STATE OF INCORPORATION: TX FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: SC 14D1/A BUSINESS ADDRESS: STREET 1: 10300 49TH ST N CITY: CLEARWATER STATE: FL ZIP: 33762 BUSINESS PHONE: 7132405588 MAIL ADDRESS: STREET 1: 10300 49TH STREET NORTH CITY: CLEARWATER STATE: FL ZIP: 33762 SC 14D1/A 1 AMENDED SCHEDULE 14D-1 =============================================================================== SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------- SCHEDULE 14D-1 (AMENDMENT NO. 3 - FINAL AMENDMENT) TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 -------------- CIRCON CORPORATION (NAME OF SUBJECT COMPANY) MMI ACQUISITION CORP. MAXXIM MEDICAL, INC. MAXXIM MEDICAL, INC. (BIDDERS) COMMON STOCK, PAR VALUE $0.01 PER SHARE (TITLE OF CLASS OF SECURITIES) 172736 10 0 (CUSIP NUMBER OF CLASS OF SECURITIES) -------------- KENNETH W. DAVIDSON PRESIDENT AND CHIEF EXECUTIVE OFFICER MAXXIM MEDICAL, INC. 10300 49TH STREET NORTH CLEARWATER, FL 33762 TELEPHONE: (727) 561-2100 FACSIMILE: (727) 561-2170 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDERS) COPY TO: MICHAEL E. GIZANG, ESQ. SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP 919 THIRD AVENUE NEW YORK, NY 10022 TELEPHONE: (212) 735-3000 FACSIMILE: (212) 735-2000 -------------- CALCULATION OF FILING FEE =============================================================================== TRANSACTION VALUATION* $219,797,445 AMOUNT OF FILING FEE $43,960 =============================================================================== * Estimated for purposes of calculating the amount of the filing fee only. This amount assumes the purchase of 14,653,163 shares of common stock, $0.01 par value per share (the "Shares"), of Circon Corporation at a price of $15.00 per Share in cash, without interest thereon. Such number of Shares represents the 13,440,490 Shares outstanding as of November 20, 1998, and assumes the issuance prior to the consummation of the Offer of 1,212,673 Shares upon the exercise or conversion of outstanding stock options and warrants. The amount of the filing fee calculated in accordance with Regulation 240.0-11 of the Securities Exchange Act of 1934, as amended, equals 1/50th of one percent of the value of the transaction. [X] Check box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. Amount Previously Paid: $43,960 Form or Registration No.: Schedule 14D-1 Filing Party: MMI Acquisition Corp., Maxxim Medical, Inc. and Maxxim Medical, Inc. Date Filed: November 30, 1998 =============================================================================== 14D-1 - --------------------- CUSIP NO. 172736 10 0 - --------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MMI ACQUISITION CORP. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,547,831 - ------------------------------------------------------------------------------- 8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) 93.2% - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 2 14D-1 - --------------------- CUSIP NO. 172736 10 1 - ---------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MAXXIM MEDICAL, INC. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,547,831 - ------------------------------------------------------------------------------- 8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) 93.2% - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 3 14D-1 - --------------------- CUSIP NO. 172736 10 1 - --------------------- - ------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS MAXXIM MEDICAL, INC. - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS BK - ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(e) OR 2(f) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION TEXAS - ------------------------------------------------------------------------------- 7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 12,547,831 - ------------------------------------------------------------------------------- 8. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7) 93.2% - ------------------------------------------------------------------------------- 10 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------- 4 TENDER OFFER This Amendment No. 3 (Final Amendment) amends and supplements the Tender Offer Statement on Schedule 14D-1 filed on November 30, 1998 (as amended and supplemented, the "Statement"), relating to the offer by MMI Acquisition Corp., a Delaware corporation ("Purchaser"), and a wholly owned subsidiary of Maxxim Medical, Inc., a Delaware corporation ("Parent"), a wholly owned subsidiary of Maxxim Medical, Inc., a Texas corporation ("Maxxim"), to purchase all of the outstanding shares of common stock, par value $0.01 per share (the "Common Stock"), including the associated preferred stock purchase rights issued pursuant to the Rights Agreement, dated as of August 14, 1996, by and between the Company (as defined below) and Chase Mellon Shareholder Services, LLC, as Rights Agent (the "Rights" and, together with the Common Stock, the "Shares"), of Circon Corporation, a Delaware corporation (the "Company"), at a price of $15.00 per Share, net to the seller in cash, without interest thereon, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated November 30, 1998, and the related Letter of Transmittal. Unless otherwise indicated, the capitalized terms used herein shall have the meanings specified in the Statement, including the Offer to Purchase previously filed as Exhibit (a)(1) hereto. ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY. The Offer expired at 5:00 p.m., New York City time, on Tuesday, January 5, 1999. Based on preliminary information provided by the Depositary, approximately 12,547,831 Shares or 93.2% of the outstanding Shares were validly tendered and not withdrawn pursuant to the Offer (including approximately 172,085 Shares subject to guarantees of delivery). Purchaser has accepted the tendered Shares for payment and has notified the Depositary to promptly pay for the tendered and accepted Shares, in accordance with the terms and subject to the conditions set forth in the Offer to Purchase and the related Letter of Transmittal. ITEM 11. MATERIALS TO BE FILED AS EXHIBITS. (a)(1) Offer to Purchase, dated November 30, 1998.* (a)(2) Letter of Transmittal.* (a)(3) Notice of Guaranteed Delivery.* (a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(6) Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.* (a)(7) Press Release, dated November 21, 1998.* (a)(8) Press Release, dated November 30, 1998.* (a)(9) Summary Advertisement.* 5 (a)(10) Press Release, dated December 10, 1998.* (a)(11) Press Release, dated January 5, 1999.* (a)(12) Press Release, dated January 6, 1999. (b)(1) Commitment Letter, dated as of November 21, 1998, by and among Maxxim, NationsBank, N.A. and NationsBanc Montgomery Securities LLC.* (b)(2) Third Amended and Restated Credit Agreement, dated as of January 4, 1999, by and among Maxxim, NationsBank, N.A., as agent, The Bank of Nova Scotia and First Union Bank, as managing agents, and the banks named therein, without exhibits.* (c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by and among Parent, Purchaser and the Company.* (c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and between Maxxim and the Company.* (d) None. (e) Not applicable. (f) None. - ---------- * Previously filed. 6 SIGNATURE After due inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: January 6, 1999 MMI ACQUISITION CORP. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: President MAXXIM MEDICAL, INC. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: Chairman of the Board, President and Chief Executive Officer MAXXIM MEDICAL, INC. By: /s/ KENNETH W. DAVIDSON ------------------------------------ Name: Kenneth W. Davidson Title: Chairman of the Board, President and Chief Executive Officer INDEX TO EXHIBITS
SEQUENTIAL EXHIBIT PAGE NO. - --------------- ----------- (a)(1) Offer to Purchase, dated November 30, 1998.* (a)(2) Letter of Transmittal.* (a)(3) Notice of Guaranteed Delivery.* (a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees.* (a)(6) Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.* (a)(7) Press Release, dated November 21, 1998.* (a)(8) Press Release, dated November 30, 1998.* (a)(9) Summary Advertisement.* (a)(10) Press Release, dated December 10, 1998.* (a)(11) Press Release, dated January 5, 1999.* (a)(12) Press Release, dated January 6, 1999. (b)(1) Commitment Letter, dated as of November 21, 1998, by and among Maxxim, NationsBank, N.A. and NationsBanc Montgomery Securities LLC.* (b)(2) Third Amended and Restated Credit Agreement, dated as of January 4, 1999, by and among Maxxim, NationsBank, N.A., as agent, The Bank of Nova Scotia and First Union Bank, as managing agents, and the banks named therein, without exhibits.* (c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by and among Parent, Purchaser and the Company.* (c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and between Maxxim and the Company.* (d) None. (e) Not applicable. (f) None.
- ---------- * Previously filed. EX-99.(A)(12) 2 PRESS RELEASE Exhibit (a)(12) FOR: MAXXIM MEDICAL, INC. APPROVED BY: Peter M. Graham Executive Vice President 727/561-2100 CONTACTS: Mary Lugris Investor Relations 727/561-2100 Morgen-Walke Associates Andrea Kaimowitz/Katherine Mittelbusher Press: Stacey Berns/Stacey Nield 212/850-5600 FOR IMMEDIATE RELEASE MAXXIM MEDICAL PURCHASES 12,547,831 SHARES REPRESENTING APPROXIMATELY 93% OF THE OUTSTANDING SHARES OF CIRCON CORPORATION CLEARWATER, FLORIDA, JANUARY 6, 1999 -- MAXXIM MEDICAL, INC. (NYSE: MAM) announced today that MMI Acquisition Corp., a wholly owned subsidiary of Maxxim Medical, has successfully completed its cash tender offer to purchase all of the outstanding shares of Circon Corporation (NASDAQ: CCON) at a price of $15.00 per share. Maxxim Medical reported that, based on a preliminary count, a total of 12,547,831 shares of Circon Corporation common stock had been tendered pursuant to the tender offer (including 172,085 shares subject to guarantees of delivery or receipt of additional documentation), which expired at 5:00 p.m., New York City time, on Tuesday, January 5, 1999, and that all such shares have been accepted for payment in accordance with the terms of the tender offer. The shares tendered constitute approximately 93% of the total outstanding Circon shares. Maxxim Medical also announced that MMI Acquisition Corp. and Circon expect to shortly effect a merger pursuant to which Circon will become a wholly owned subsidiary of Maxxim Medical and all holders of Circon shares (other than MMI Acquisition Corp.) that were not tendered will have the right to receive the same $15.00 per share in cash payable pursuant to the tender offer. Maxxim Medical is a major, diversified manufacturer, distributor and marketer of disposable specialty medical products such as custom procedure trays, medical gloves, electrosurgical systems and disposable products for use in cardiology, radiology and critical care. # # # -----END PRIVACY-ENHANCED MESSAGE-----